This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Alto Neuroscience Class Action Lawsuit
Business class action

Alto Neuroscience Class Action Lawsuit

Analysis based on 14 articles · First reported Jul 25, 2025 · Last updated Aug 24, 2025

Sentiment
-50
Attention
2
Articles
14
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Alto Neuroscience could negatively impact its stock price and investor confidence due to allegations of misleading statements about its drug ALTO-100. Investors who purchased Alto Neuroscience securities during the Class Period may be entitled to compensation.

Biotechnology Legal Services
Event Summary

Rosen Law Firm has filed a class action lawsuit against Alto Neuroscience, Inc. on behalf of investors who purchased common stock during its initial public offering on or about February 2, 2024, and/or securities between February 2, 2024, and October 22, 2024. The lawsuit alleges that Alto Neuroscience made materially false and misleading statements regarding the effectiveness of its drug ALTO-100 in treating major depressive disorder, overstating its clinical, regulatory, and commercial prospects. Investors are encouraged to secure counsel before the September 19, 2025, lead plaintiff deadline.

Entities Involved
stock
Alto Neuroscience
Alto Neuroscience is facing a class action lawsuit for allegedly making false and misleading statements regarding the effectiveness of its drug ALTO-100 for major depressive disorder, which could lead to significant financial and reputational damage.
Importance 100.0 Sentiment -70.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
per
Philip Kim
Importance 0.0 Sentiment 0.0
per
Lawrence Rosen
Importance 0.0 Sentiment 0.0
Relationships
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Philip Kim attorney ↔ Lawrence Rosen Philip Kim is an attorney at the Rosen Law Firm, working under the direction of founding partner Lawrence Rosen. Kim fre
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.